Shilpa Medicare recalls

Shilpa Medicare has 8 recalls on record with the FDA and USDA, the earliest in 2020 and the latest reported on 26 Aug 2026. 2 are still ongoing. 2 were reported in the last 12 months. The most frequent reason is manufacturing (cgmp) deviations.

Total recalls8since 2020

Last 12 months2reported

Class I00% of total

Ongoing2latest 26 Aug 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 2 0

Severity split

Class I 0 0%Class II 8 100%Class III 0 0%

Why shilpa medicare is recalled

Product types

Injectable & IV Drugs675%
Cancer Medication225%

Brands

By year

2026225%
2020675%

Ongoing shilpa medicare recalls

2 active

Reported	Class	Recall	Company	Reason	Where
26 Aug 2026Drug	CLASS II	Pemrydi RTU(pemetrexed injection), 500 mg/ (10 mg/mL) recalledPemrydi Rtu	Shilpa Medicare	Other	Nationwide
26 Aug 2026Drug	CLASS II	Pemrydi RTU (pemetrexed injection), 100 mg/ (10 mg/mL) recalledPemrydi Rtu	Shilpa Medicare	Other	Nationwide

All shilpa medicare recalls, newest first

8 total

Reported	Class	Recall	Company	Reason	Where
26 Aug 2026Drug	CLASS II	Pemrydi RTU(pemetrexed injection), 500 mg/ (10 mg/mL) recalledPemrydi Rtu	Shilpa Medicare	Other	Nationwide
26 Aug 2026Drug	CLASS II	Pemrydi RTU (pemetrexed injection), 100 mg/ (10 mg/mL) recalledPemrydi Rtu	Shilpa Medicare	Other	Nationwide
16 Dec 2020Drug	CLASS II	Imatinib Mesylate Tablets 100 mg recalled by Shilpa MedicareImatinib Mesylate	Shilpa Medicare	Manufacturing (CGMP) Deviations	Nationwide
16 Dec 2020Drug	CLASS II	Busulfan Injection 60 mg/ (6 mg/mL) recalled by Shilpa Medicare	Shilpa Medicare	Sterility	Nationwide
16 Dec 2020Drug	CLASS II	Docetaxel Injection USP 160 mg/ (20 mg/mL) recalled by Shilpa Medicare	Shilpa Medicare	Manufacturing (CGMP) Deviations	Nationwide
16 Dec 2020Drug	CLASS II	Azacitidine for Injection 100 mg/vial, For Subcutaneous recalled	Shilpa Medicare	Manufacturing (CGMP) Deviations	Nationwide
16 Dec 2020Drug	CLASS II	Imatinib Mesylate Tablets 400 mg recalled by Shilpa MedicareImatinib Mesylate	Shilpa Medicare	Manufacturing (CGMP) Deviations	Nationwide
16 Dec 2020Drug	CLASS II	Azacitidine for Injection 100 mg/vial, For Subcutaneous recalledAzacitidine	Shilpa Medicare	Manufacturing (CGMP) Deviations	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.